According to CoinMeta, Shisiyao Group has announced that it has obtained the drug production registration approval from the China National Medical Products Administration for peritoneal dialysis fluid (bicarbonate - G1.5 %) (2000ml), which falls under Class 3 of chemical drugs. This is considered to be in compliance with the consistency evaluation requirements and is mainly used for peritoneal dialysis in patients with chronic renal failure, especially when hypermagnesemia has not been adequately improved.